| Literature DB >> 30409112 |
Song Ren1, Xin Yi Li1, Fang Wang1, Ping Zhang1, Yuan Zhang1, Gui Sen Li1, Li Wang1, Xiang Zhong2.
Abstract
BACKGROUND: Kimura's disease (KD) is a rare chronic inflammatory disorder with a high incidence of renal involvement. In this report, we present a case study of KD-associated nephrotic syndrome combined with minimal change disease (MCD) and acute renal tubular injury. Meanwhile, the clinical and histopathological characteristics of 26 patients with KD presenting with renal involvement were retrospectively evaluated. CASEEntities:
Keywords: Kimura’s disease; Minimal change disease; Nephrotic syndrome; Prednisone
Mesh:
Year: 2018 PMID: 30409112 PMCID: PMC6225567 DOI: 10.1186/s12882-018-1123-y
Source DB: PubMed Journal: BMC Nephrol ISSN: 1471-2369 Impact factor: 2.388
Fig. 1Histological examination of a lymph node biopsy. a. The micrograph shows reactive follicles and vascular proliferation (arrow; H&E staining × 100); b. Image showing eosinophil in filtration and the formation of an eosinophilic microabscess (arrow; H&E staining × 400)
Fig. 2Histological examination of a renal biopsy. a. Light microscopy image showing the basically normal of the glomerulus with a flattened renal tubular epithelium, a slightly dilated lumen, and the presence of a few protein cysts in the dilated tubules (arrow; H&E staining × 200). b. Image of a minor glomerular lesion(arrow; H&E staining × 400). C. electron microscopy image showing mild hyperplasia of the mesangial cells and stromal cells and the extensive fusing of podocyte processes of the epithelial cells (arrow)
Fig. 3Serial biochemical changes observed in the patient. a. The change in renal function. After 6 weeks of treatment, the urea nitrogen concentration decreased to 12.55 mmol/L, the serum creatinine concentration decreased to 69.4 μmol/L and the eGFR increased to 97.8 mL/min. b. The change in serum albumin concentrations. The serum albumin concentration increased to 37.5 g/L after 6 weeks of treatment
Clinical features, pathology of the kidney and lymph nodes and treatments administered of 26 patients with KD-associated nephrotic syndrome
| Reported by | Case | Country | Gender | Age | Urine protein | Serum albumin | Serum creatinine(umol/L) | Serum IgE | Eosinophils | Renal biopsy | Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|
| X W Xiao | 1 | China | Male | 23 | 12.77 | 34.6 | 88 | 582 | 0.44 | Mesangial proliferation | Steroid+TW |
| X F Zhang | 2 | China | Male | 46 | 6 | 26.3 | 62.9 | 43.4 | 0.15 | Minimal change disease | Steroid |
| P C Li | 3 | China | Male | 49 | 10.07 | 15.7 | 75 | 0.27 | Mesangial proliferation | Steroid | |
| H Sun | 4 | China | Male | 40 | 8.34 | 30.8 | 480 | 0.15 | Acute tubular necrosis | Steroid | |
| Y W Zhang | 5 | China | Male | 23 | 6.05 | 23 | 2500 | IgA nephropathy | Steroid+CTX | ||
| L L Shao | 6 | China | Male | 42 | 0.27 | 131 | 1316 | 0.354 | IgA nephropathy | MMF | |
| J L Meng | 7 | China | Male | 43 | 6 | 15.5 | 115 | 0.574 | Membranous nephropathy | Steroid | |
| R Duan | 8 | China | Male | 19 | 39.9 | 944 | 3000 | 0.154 | FSGS | Steroid | |
| 9 | China | Femal | 35 | 0.84 | 31.2 | 500 | 0.015 | Mesangial proliferation | Steroid | ||
| C B Liu | 10 | China | Male | 19 | 3.65 | 97.1 | 272 | 0.32 | Membranous nephropathy | Steroid | |
| 11 | China | Male | 21 | 5.32 | 185 | 397 | 0.17 | IgA nephropathy | Steroid+TW | ||
| 12 | China | Male | 36 | 14.1 | 123.76 | 620 | 0.1 | Membranous nephropathy | Steroid+CTX | ||
| 13 | China | Male | 25 | 12.8 | 88.4 | 989 | 0.44 | Mesangial proliferation | Steroid+TW | ||
| 14 | China | Male | 14 | 8.65 | 53.04 | 172 | 0.056 | Mesangial proliferation | Steroid+LEF | ||
| 15 | China | Male | 44 | 7.28 | 44.2 | 107 | 0.168 | Mesangial proliferation | Steroid+LEF | ||
| 16 | China | Male | 53 | 6.99 | 176.8 | 160 | 0.122 | Mesangial proliferation | Steroid+CTX | ||
| 17 | China | Male | 48 | 5.27 | 79.56 | 1378 | 0.26 | Membranous nephropathy | Steroid | ||
| Y G Sha | 18 | China | Male | 5 | 3.5 | 20.6 | 30 | 2000 | 0.21 | Mesangial proliferation | Steroid |
| Koich | 19 | Japan | Male | 9 | 11.1 | 12 | 238 | 4981 | 0.48 | Minimal change disease | Steroid |
| Fatih | 20 | Turkey | Male | 21 | 17.3 | 10 | 256 | 1987 | 0.21 | FSGS | Steroid+CsA |
| Deepak | 21 | Vietnam | Male | 14 | 4 | 21 | 123 | 0.11 | Mesangial proliferation | Steroid | |
| Chan | 22 | China | Male | 25 | 19.7 | 18 | 85 | 1918 | Mesangial proliferation | Steroid | |
| S L Zhu | 23 | China | Male | 23 | 9.3 | 16 | 1510 | 0.485 | FSGS | Steroid | |
| Mohamed | 24 | Egypt | Male | 50 | 8.9 | 9 | 212 | 0.2 | Membranous nephropathy | Steroid+MMF | |
| K Sud | 25 | India | Femal | 24 | 4.1 | 15 | 160 | Minimal change disease | Steroid | ||
| Surendra | 26 | India | Male | 18 | 8.6 | 21 | 62 | 0.03 | Mesangial proliferation | Steroid |
TW Tripterygium wilfordii, CTX Cyclophosphamide, MMF Mycophenolate mofetil, LEF Leflunomide, CsA Cyclosporine